BioMarin Pharmaceuticals Inc BMRN
$57.67
-2.25%
at last close
Financials (TTM)
- Revenue
- $3.24 billion
- Net Income
- $268.74 million
- Net Margin
- 8.29%
- Return on Equity
- 4.33%
- Debt-to-Equity
- 0.23
- P/E Ratio
- 42.09
- Price / Book
- 1.84
- Price / Sales
- 3.52
Over the trailing twelve months, BioMarin Pharmaceuticals Inc generated revenue of $3.24 billion and net income of $268.74 million, a net margin of 8.29%.
At the last closing price of $57.67, BMRN trades at 42.09 times trailing earnings and 3.52 times sales, with a market capitalization of $11.40 billion.
Key Stats
- Last Close
- $57.67
- Market Cap
- $11.40 billion
- 52-Week Range
- $49.26 – $66.28
- Average Volume
- 2.45 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.